Search

C 臂 CT 引導下微波消融治療非小細胞肺癌的近期療效觀察

目的探討 C 臂 CT 引導下微波消融治療非小細胞肺癌的安全性及有效性，總結圍術期并發癥的危險因素及處理辦法。方法回顧性分析 2014 年 10 月至 2016 年 10 月我院46例非小細胞肺癌患者在 C 臂 CT 引導下行微波消融治療的臨床資料，其中男 34 例、女 12 例，年齡 71（44～83）歲。分析無進展生存期、總生存期、圍術期并發癥。結果46 例患者實施了微波消融治療，消融功率 60（45～70）W，消融時間 8（4～15）min。成功率 100.00%，完全消融率 84.91%（45/53），中位隨訪時間為 14（5～24）個月, 1、2 年生存率為 74.31%、28.36%；中位無進展生存期為 13 個月［95%CI（10.42，15.58）］，中位總生存期為 16 個月［95%CI（13.24，18.76）］。并發癥發生率 19.57%（9/46），其中氣胸 8.69%（4/46）；不良反應發生率 43.48%（20/46），其中胸痛 30.43%（14/46），圍術期無嚴重并發癥。結論C 臂 CT 引導下經皮微波消融治療非小細胞肺癌是一種安全、有效的治療方法，值得推廣。

心臟瓣膜病合并巨大左心室51例術后近中期療效觀察

Epidemiological research on inpatients with skin cancer in China

ObjectivesTo analyze the epidemiological characteristics of inpatients with skin cancer in China.MethodsThe medical records of all inpatients with skin cancer in second-level and above hospitals in China from 2015 to 2017 were collected, and the demographic characteristics and regional distribution of inpatients were retrospectively analyzed.ResultsFrom 2015 to 2017, the quantity of inpatients with skin cancer in China increased annually. The ratio of male to female was 1.09 to 1, individuals aged 60 to 70 were high incidence age group, and the occupation was primarily farmers. Guangdong province had the largest quantity of inpatients. Among geographic regions, the proportion of inpatients in East China was the largest (34.20%). Among economic regions, the proportion of inpatients in the east was the largest (45.86%).ConclusionsThe quantity of inpatients with skin cancer in China is on the rise, and there are obvious spatial differences. Therefore, more attention should be paid to the prevention and treatment of skin cancer.